RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Growth Mixture Modeling (Gmm) to Determine Treatment Effects of Canagliflozin Versus Sitagliptin on Weight-Related Quality of Life (Wrqol) in Subjects with Type 2 Diabetes Mellitus (T2Dm)
Stull, D., Houghton, K., & Traina, SB. (2013). Growth Mixture Modeling (Gmm) to Determine Treatment Effects of Canagliflozin Versus Sitagliptin on Weight-Related Quality of Life (Wrqol) in Subjects with Type 2 Diabetes Mellitus (T2Dm). Value in Health, 16(7), A447-A447.